EyePoint Pharmaceuticals (EYPT) Financials: Revenue & Earnings

EYPT price $0.39 +0.02 +6.44%

Ticker
EYPT
Price
$0.39
Change
+0.02 +6.44%
Market cap ?
$32.41M
Beta ?
1.68
Sector
Healthcare
Industry
Biotechnology

Fair value

EYPT fair value $10.36. Price $0.39. Price is 96% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 6.31M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.7). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 83.84M. Net debt -79.03M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare EYPT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.93—231.15K
2026-08-05-1.09-1.01507.00K443.00K
2026-05-06-0.99-0.79696.00K352.83K
2026-03-04-0.81-0.78620.00K994.46K
2025-11-05-0.85-0.77966.00K1.01M
2025-08-06-0.85-0.675.33M4.13M
2025-05-07-0.65-0.6524.45M6.82M
2025-03-05-0.64-0.5411.59M8.19M
2024-11-07-0.54-0.4810.52M10.56M
2024-08-07-0.58-0.559.48M9.59M
2024-05-08-0.55-0.3411.68M9.98M
2024-03-07-0.33-0.6014.03M8.90M
2023-11-01-0.33-0.6215.20M8.71M
2023-08-02-0.610.419.11M51.92M
2023-05-03-0.56-0.657.68M7.43M
2023-03-02-0.61-0.6310.50M10.40M
2022-11-02-0.49-0.7010.01M10.93M
2022-08-03-0.52-0.5711.56M10.86M
2022-05-04-0.52-0.509.29M9.89M
2022-03-03-0.59-0.5011.54M9.79M
2021-11-03-0.58-0.479.06M9.84M
2021-08-04-0.35-0.459.01M9.01M
2021-05-05-0.50-0.537.32M8.06M
2021-03-04-1.010.457.13M15.73M
2020-11-05-0.30-0.1015.70M4.08M
2020-08-05-1.00-1.104.12M4.12M
2020-05-06-1.10-1.007.49M6.81M
2020-03-05-0.90-1.208.63M10.36M
2019-11-07-1.40-1.402.51M2.34M
2019-08-07-1.10-1.307.21M7.87M
2019-05-08-1.60-1.302.01M1.41M
2019-03-14-1.20-1.402.44M2.85M
2018-11-06-1.90-1.30486.00K165.68K
2018-09-12-1.90-0.90715.00K127.74K
2018-05-08-1.50-1.30928.00K806.00K
2018-02-07-0.13-0.15933.00K1.07M
2017-11-07-1.50-1.50385.00K390.00K
2017-09-11-1.60-1.50701.00K656.25K
2017-05-04-1.50-1.50590.00K590.00K
2017-02-07-0.02-1.835.97M10.16M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-20Elston GeorgeBuy5.00K——
2026-08-20Elston GeorgeBuy64.95K——
2026-08-20Elston GeorgeSell64.95K——
2026-08-20Elston GeorgeSell5.00K——
2026-08-18Zaderej Karen L.Buy10.60K$4.9352.26K
2026-07-10Duker Jay S.Buy16.67K——
2026-07-10Duker Jay S.Sell8.06K$14.72118.63K
2026-07-10Duker Jay S.Sell16.67K——
2026-06-30Ribeiro RamiroSell2.44K$8.2620.13K
2026-06-30Ribeiro RamiroSell2.44K$8.2620.14K
2026-06-30Ribeiro RamiroBuy2.44K$8.2620.14K
2026-06-30Ribeiro RamiroSell2.44K$15.0036.55K
2026-06-30Ribeiro RamiroBuy2.44K$8.2620.13K
2026-06-30Ribeiro RamiroSell2.44K$15.0236.61K
2026-05-25Elston GeorgeBuy7.50K——
2026-05-25Elston GeorgeSell3.63K$12.9346.90K
2026-05-25Elston GeorgeSell7.50K——
2026-04-17Ribeiro RamiroSell2.44K$8.2620.13K
2026-04-17Ribeiro RamiroBuy2.44K$8.2620.13K
2026-04-17Ribeiro RamiroSell2.44K$15.0036.55K
2026-03-23Duker Jay S.Buy76.77K$13.111.01M
2026-03-23Duker Jay S.Buy97.50K$20.401.99M
2026-03-23Duker Jay S.Sell97.50K$20.401.99M
2026-03-23Duker Jay S.Buy52.50K$13.13689.33K
2026-03-23Duker Jay S.Sell52.50K$13.13689.33K
2026-03-23Duker Jay S.Sell76.77K$13.111.01M
2026-03-16Duker Jay S.Buy1.50K$13.1519.72K
2026-03-04Ribeiro RamiroSell2.44K$8.2620.14K
2026-03-04Ribeiro RamiroBuy2.44K$8.2620.14K
2026-03-04Ribeiro RamiroSell2.44K$17.8743.57K
2026-03-02Elston GeorgeSell5.00K——
2026-03-02Elston GeorgeBuy5.00K——
2026-02-17Ribeiro RamiroSell2.44K$8.2620.13K
2026-02-17Ribeiro RamiroBuy2.44K$8.2620.13K
2026-02-17Ribeiro RamiroSell2.44K$15.0036.55K
2026-01-06Lurker NancyBuy75.13K——
2026-01-06Lurker NancySell75.13K——
2026-01-06Duker Jay S.Buy20.79K——
2026-01-06Duker Jay S.Sell10.05K$16.86169.51K
2026-01-06Duker Jay S.Sell20.79K——
2026-01-06Elston GeorgeBuy15.29K——
2026-01-06Elston GeorgeSell4.49K$16.8675.65K
2026-01-06Elston GeorgeSell15.29K——
2026-01-05Ribeiro RamiroSell29.25K$8.26241.60K
2026-01-05Ribeiro RamiroBuy29.25K$8.26241.60K
2026-01-05Ribeiro RamiroSell42.54K$17.10727.32K
2026-01-05Duker Jay S.Buy30.00K——
2026-01-05Duker Jay S.Sell14.51K$17.43252.82K
2026-01-05Duker Jay S.Sell30.00K——
2026-01-05Elston GeorgeBuy15.00K——
2026-01-05Elston GeorgeSell4.40K$17.4376.74K
2026-01-05Elston GeorgeSell15.00K——
2026-01-05Lurker NancyBuy12.67K——
2026-01-05Lurker NancySell12.67K——
2026-01-03Ribeiro RamiroSell19.67K——
2026-01-03Ribeiro RamiroBuy19.67K——
2026-01-03Ribeiro RamiroSell6.37K$17.48111.40K
2026-01-03Duker Jay S.Sell65.00K——
2026-01-03Duker Jay S.Buy65.00K——
2026-01-03Duker Jay S.Sell23.45K$17.48409.85K
2026-01-03Elston GeorgeBuy19.67K——
2026-01-03Elston GeorgeSell6.32K$17.48110.54K
2026-01-03Elston GeorgeSell19.67K——
2026-01-02Ribeiro RamiroBuy171.40K$17.483.00M
2026-01-02Ribeiro RamiroBuy85.70K——
2026-01-02Duker Jay S.Buy331.00K$17.485.79M
2026-01-02Duker Jay S.Buy165.00K——
2026-01-02Elston GeorgeBuy126.00K$17.482.20M
2026-01-02Elston GeorgeBuy63.00K——
2026-01-02Zaderej Karen L.Buy40.00K$17.48699.20K
2026-01-02Sanders Reginald J.Buy40.00K$17.48699.20K
2026-01-02Lurker NancyBuy40.00K$17.48699.20K
2026-01-02Landis John B.Buy40.00K$17.48699.20K
2026-01-02Duty StuartBuy40.00K$17.48699.20K
2026-01-02Hassan FredBuy40.00K$17.48699.20K
2026-01-02DICICCO WENDY FBuy40.00K$17.48699.20K
2026-01-02ANDO GORANBuy41.50K$17.48725.42K
2025-12-19Elston GeorgeSell5.00K——
2025-12-19Elston GeorgeBuy5.00K——
2025-12-04Cormorant Asset Management, LPSell60.00K$15.70942.24K
2025-12-04Lurker NancySell9.30K$15.11140.48K
2025-11-28Lurker NancySell500$14.957.47K
2025-11-26Lurker NancySell200$14.952.99K
2025-11-11Ribeiro RamiroSell2.72K$11.6131.60K
2025-09-19Elston GeorgeSell20.00K——
2025-09-19Elston GeorgeBuy20.00K——
2025-07-11Zaderej Karen L.Buy2.00K——
2025-07-11Zaderej Karen L.Sell2.00K——
2025-07-10Lurker NancyBuy11.11K——
2025-07-10Lurker NancySell11.11K——
2025-07-10Duker Jay S.Buy16.67K——
2025-07-10Duker Jay S.Sell16.67K——
2025-07-10Duker Jay S.Sell7.69K$11.0685.03K
2025-07-02Lurker NancyBuy103.31K$3.26336.78K
2025-07-02Lurker NancyBuy31.16K$13.13409.20K
2025-07-02Lurker NancyBuy55.00K$10.13557.15K
2025-07-02Lurker NancySell103.31K$3.26336.78K
2025-07-02Lurker NancySell27.27K$20.40556.31K
2025-07-02Lurker NancySell55.00K$10.13557.15K
2025-07-02Lurker NancySell15.28K$9.11139.18K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 209, holders +5 vs prior quarter. Ownership 108.01%.

HolderSharesChangeChange %Value
MONTANOVA CAPITAL, LLC8.30M00.00%118.64M
BLACKROCK, INC.7.46M285.86K+3.98%106.72M
CORMORANT ASSET MANAGEMENT, LP7.00M-1.26M-15.31%100.10M
FEDERATED HERMES, INC.5.68M11.46K+0.20%81.24M
ADAGE CAPITAL PARTNERS GP, L.L.C.4.83M1.53M+46.30%69.04M
FRANKLIN TEMPLETON INC4.81M-241.52K-4.78%68.74M
COMMODORE CAPITAL LP4.60M1.77M+62.83%65.78M
JUPITER TOPCO LLC3.77M3.77MNew53.90M
VANGUARD CAPITAL MANAGEMENT LLC3.63M70.68K+1.99%51.91M
PARADIGM BIOCAPITAL ADVISORS LP2.89M-252.04K-8.02%41.33M
STATE STREET CORP2.36M260.34K+12.41%33.71M
GEODE CAPITAL MANAGEMENT, LLC2.06M78.72K+3.97%29.50M
ABERDEEN GROUP PLC2.01M270.42K+15.56%28.73M
PERCEPTIVE ADVISORS LLC2.00M2.00MNew28.60M
CITADEL ADVISORS LLC1.98M1.88M+1889.55%28.28M
BALYASNY ASSET MANAGEMENT L.P.1.81M373.62K+25.97%25.92M
PARKMAN HEALTHCARE PARTNERS LLC1.29M-66.64K-4.92%18.42M
EVENTIDE ASSET MANAGEMENT, LLC1.25M00.00%17.81M
TWO SIGMA INVESTMENTS, LP1.18M750.83K+174.48%16.89M
ESSEX WOODLANDS MANAGEMENT, INC.1.08M00.00%15.51M
ORBIMED ADVISORS LLC1.07M00.00%15.29M
5AM VENTURE MANAGEMENT, LLC1.05M00.00%15.02M
ROSALIND ADVISORS, INC.988.23K-48.51K-4.68%14.13M
VANGUARD PORTFOLIO MANAGEMENT LLC971.01K177.14K+22.31%13.89M
AMERIPRISE FINANCIAL INC848.41K425.15K+100.45%12.13M

Earnings and financials

EyePoint Pharmaceuticals, Inc. (EYPT) trades at $0.39, with a market cap of $32.41M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

EyePoint Pharmaceuticals (EYPT) Financials: Revenue & Earnings

EYPT$0.39+0.02 +6.44%

$32.41M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History